Latest Regulatory Approvals News

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.

The Federal Court of Australia has approved the acquisition schemes for Global Uranium and Enrichment Limited by Snow Lake Resources, setting the stage for a significant shift in shareholder structure and market listing.

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Verity Resources is raising approximately $2 million through a non-renounceable entitlement offer to advance its Monument Gold and Botswana copper-silver projects, with directors backing the move through participation and underwriting.

Noronex Limited has exercised its option to acquire a 51% stake in the Etango North Uranium Project in Namibia, initiating a maiden drilling program backed by AI-driven exploration techniques.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

The Tennant Creek Copper Alliance, comprising CuFe, Emmerson Resources, and Tennant Minerals, has secured $600,000 in government grants matched by the companies to fund a feasibility study for a shared critical minerals processing facility in Tennant Creek.

Aura Consolidated Group Inc. is set to acquire Qoria Limited in a landmark $3 billion merger, creating a global leader in digital safety solutions with a new ASX listing under the ticker AXQ.